Accelerate RX
Accelerate RX
Accelerate RX

CLINICAL TRIAL ACCELERATION

Successful and on-time pivotal clinical trials are crucial for delivering new and improved treatments for patients with serious illnesses and unlocking lucrative market opportunities for the trial sponsors. However, delays in completing these trials are exceedingly common

We unlock strategies and tactics that shorten the time it takes to bring new drugs and therapies to patients. With clinical trial acceleration, we offer external insights, new ways of thinking, and make the connections needed in:

 

Finding the right sites
Finding new patients
Avoiding patient loss
Assuring effectiveness
 

Results and outcome

We enabled a leading Biotech company to take over a year off their pivotal trial’s time to completion and submission

  1. A clinical trial for a chronic, complex autoimmune disorder
  2. The disease affects a hundred per million; finding patients was very challenging
  3. The trial was trending towards a 14-month delay with $mm in operational costs 
  4. Evaluate projected $1.2 billion in sales in four years if the product was launched ahead of the competition
  5. With ADL support, the trial was brought in 16 months earlier than the projected trend, two months ahead of the corporate baseline target

 

CLINICAL TRIAL ACCELERATION RESULTS

  • Patient-centric focus
  • AI in site identification
  • Rapid and continuous feedback (esp. COVID-19)
  • Competitive modelling
  • Data-driven projections
  • One-source of truth dash
  • Multi-vendor incentives

Top level approach

Our approach is proprietary and marries deep therapy area knowledge, data and analytics with solution execution to accelerate clinical trials

 
Card image cap
 

01  DISCOVER the key levers..

Discover the current gaps, trial trajectory and “what it takes to win”

Card image cap
 

02  MOBILIZE the organization..

Inspire the trial team and align on all points to drive the desired outcome

Card image cap
 

03  ACCELERATE smartly

Implement with excellence while constantly measuring the effectiveness of the accelerators

Our approach is effective and delivers immediate impact

 
 

Our end-to-end framework is used to ensure diligence in opportunity assessment at a very granular level of detail

 
 

Track Record

We bring extensive experience of accelerating clinical trials for different sponsors across multiple therapy areas

EXTENSIVE BREADTH OF CLINICAL TRIAL ACCELERATION EXPERIENCE

 

 

Track Record

ADL has no equal in trial acceleration; our approach uses a data-driven approach to effectively deliver results very quickly

GET IN
TOUCH

Contact a member of our team on the link below.

 

Contact Us

BEN ENEJO
PARTNER, BOSTON
BEN VAN DER SCHAAF
PARTNER, NEW YORK
CRAIG WYLIE
PARTNER, BOSTON

 

SHREYA MODI
MANAGER, NEW YORK
EMMANUEL AISABOKHAE
PRINCIPAL, NEW YORK
Pan Xi
MANAGER, BOSTON